Merantix

Graph Therapeutics is a biotechnology company specializing in precision immunology. It uses artificial intelligence and multi-omics data derived from primary patient cell samples to understand and treat immune-driven diseases. By modeling perturbations in these samples, Graph aims to deliver targeted therapies and biomarkers, addressing the unmet needs of patients with complex immune-mediated diseases.

Briink employs artificial intelligence to automate workflows for sustainable finance teams, focusing on environmental, social, and governance (ESG) audits. Its platform assists private equity firms in assessing regulatory compliance and making informed investment decisions, while helping companies enhance their sustainability profiles and promote ESG data transparency.

Graph Therapeutics is a biotechnology company specializing in precision immunology. It uses artificial intelligence and multi-omics data derived from primary patient cell samples to understand and treat immune-driven diseases. By modeling perturbations in these samples, Graph aims to deliver targeted therapies and biomarkers, addressing the unmet needs of patients with complex immune-mediated diseases.

Cambrium harnesses synthetic biology, machine learning, and lab automation to develop high-performance biomaterials. Its platform creates novel protein-based materials, including micro-molecular collagen for skin care formulations, addressing global challenges while aligning economic and environmental incentives.

Ovom Care is a healthcare company specializing in reproductive care. It offers personalized fertility services including assessment, preservation, treatments, donor services, egg freezing, and IVF, empowering patients to make informed decisions about their fertility.

Deltia is an AI-driven platform that enhances manual assembly processes. It uses computer vision to capture real-time video streams of tasks, analyzes them with flexible AI to identify improvement opportunities, aggregates data for insights, and enables data-driven process improvements.

Make your Legal work effortlessly efficient. Our LLM delivers unprecedented legal accuracy while removing the complexity of AI prompting and automation. Our AI workflows chain autonomous AI agents together to automate entire processes, just like in a law firm with specialised teams.

We build AI coaches that hyper-personalize mental health, starting with adult ADHD

Ovom Care is a healthcare company specializing in reproductive care. It offers personalized fertility services including assessment, preservation, treatments, donor services, egg freezing, and IVF, empowering patients to make informed decisions about their fertility.

Deltia is an AI-driven platform that enhances manual assembly processes. It uses computer vision to capture real-time video streams of tasks, analyzes them with flexible AI to identify improvement opportunities, aggregates data for insights, and enables data-driven process improvements.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Looks is a mobile application that enables users to customize outfits based on the occasion. Looks was founded in 2022 and was headquartered in Berlin, Germany.

Briink employs artificial intelligence to automate workflows for sustainable finance teams, focusing on environmental, social, and governance (ESG) audits. Its platform assists private equity firms in assessing regulatory compliance and making informed investment decisions, while helping companies enhance their sustainability profiles and promote ESG data transparency.

Cambrium harnesses synthetic biology, machine learning, and lab automation to develop high-performance biomaterials. Its platform creates novel protein-based materials, including micro-molecular collagen for skin care formulations, addressing global challenges while aligning economic and environmental incentives.

Kausa is a company that specializes in data analysis, offering solutions tailored to industries such as media and entertainment, gaming, marketplaces, and e-commerce. It has developed an analytics platform that assists businesses in making data-driven decisions by testing various hypotheses and providing accurate explanations for fluctuations in performance metrics. This enables organizations to understand the reasons behind changes in their key performance indicators (KPIs) and take informed actions to enhance their overall performance. Kausa's services aim to facilitate a deeper understanding of data dynamics within organizations.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Driven by digitalisation, ADAS and automated driving, automotive companies face one of their biggest challenges yet: the amount of data they are collecting is exploding. Most organisations use less than 5% of what they collect, are not able not commercialise their most valuable asset and instead waste millions on excess storage. To address this challenge, we have developed SiaSearch the category-leading search engine for petabyte-scale automotive data. Our technology automatically structures raw sensor data based on semantic attributes and keywords such as cut-ins, crowded intersections or dangerous overtaking. This metadata is powerful. By searching it, we can eliminate the time wasted on manual data crawling, automate the decision of what data to store and provide intelligent suggestions of what data would be most valuable to collect. With SiaSearch we are helping our customers to build smaller, higher density data sets. This does not just fast track their development but enables them to commercialise their data as an asset.

Merantix Momentum is a technology company that specializes in artificial intelligence (AI) services. It employs a team of skilled machine learning engineers, problem solvers, and creative thinkers who work together to help businesses across various industries leverage their potential through AI. The company offers a comprehensive AI strategy, tailored AI services, and reliable AI operations, designed to deliver long-term impact. They focus on machine learning, deep learning, and computer vision, translating their leading AI research into customized services that create domain-specific value.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.